Advertisement

A qualitative study of digoxin injection before dilation and evacuation

      Abstract

      Objective

      We sought to qualitatively understand patients’ experiences with digoxin as a step before dilation and evacuation (D&E).

      Study design

      We recruited English-speaking women from one abortion health center where digoxin is routinely used before D&E. We interviewed participants one to three weeks after the D&E about physical and emotional experiences with digoxin and understanding of its purpose. Using grounded theory, we analyzed transcripts iteratively, identifying themes from interviews; we stopped recruitment when we reached thematic saturation.

      Results

      We conducted 20 interviews and participants described mixed experiences. Three overarching themes from the qualitative interviews were: (1) physical and emotional discomfort; (2) varied understanding of digoxin’s purpose and effects; and (3) reassurance. Most participants described significantly negative experiences with digoxin; however, many participants also described positive aspects of the injection intermingled with those negative experiences.

      Conclusions

      Participants’ experiences with digoxin before D&E were both polarized and nuanced. While participants were largely clear about digoxin’s action, they were much less clear about the reason for its use.

      Implications

      Both the clinical purpose for and patients’ experiences with digoxin before D&E are complicated. Providers who continue to use digoxin should consider patient preferences in how they offer digoxin, and consider tools to ensure patient understanding.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jones R.K.
        • Jerman J.
        Abortion Incidence and Service Availability In the United States, 2014.
        Perspect Sex Reprod Health. 2017; https://doi.org/10.1363/psrh.12015
        • Haddad L.
        • Yanow S.
        • Delli-Bovi L.
        • Cosby K.
        • Weitz T.A.
        Changes in abortion provider practices in response to the Partial-Birth Abortion Ban Act of 2003.
        Contraception. 2009; 79: 379-384https://doi.org/10.1016/j.contraception.2008.11.010
        • Hammond C.
        Recent advances in second-trimester abortion: an evidence-based review.
        Am J Obstet Gynecol. 2009; 200: 347-356https://doi.org/10.1016/j.ajog.2008.11.016
        • Greene M.F.
        The intimidation of American physicians--banning partial-birth abortion.
        N Engl J Med. 2007; 356: 2128-2129https://doi.org/10.1056/NEJMp078084
        • Diedrich J.
        • Drey E.
        • Society of Family Planning
        Induction of fetal demise before abortion.
        Contraception. 2010; 81: 462-473https://doi.org/10.1016/j.contraception.2010.01.018
        • Nucatola D.
        • Roth N.
        • Gatter M.
        A randomized pilot study on the effectiveness and side-effect profiles of two doses of digoxin as fetocide when administered intraamniotically or intrafetally prior to second-trimester surgical abortion.
        Contraception. 2010; 81: 67-74https://doi.org/10.1016/j.contraception.2009.08.014
        • Paul Maureen
        • Lichtenberg Steve
        • Borgatta Lynn
        • Grimes David A.
        • Stubblefield Phillip G.
        Management of Unintended and Abnormal Pregnancy: Comprehensive Abortion Care.
        1st ed. Wiley, 2009
        • Jackson R.A.
        • Teplin V.L.
        • Drey E.A.
        • Thomas L.J.
        • Darney P.D.
        Digoxin to facilitate late second-trimester abortion: a randomized, masked, placebo-controlled trial.
        Obstet Gynecol. 2001; 97: 471-476
        • Molaei M.
        • Jones H.E.
        • Weiselberg T.
        • McManama M.
        • Bassell J.
        • Westhoff C.L.
        Effectiveness and safety of digoxin to induce fetal demise prior to second-trimester abortion.
        Contraception. 2008; 77: 223-225https://doi.org/10.1016/j.contraception.2007.10.011
        • Dean G.
        • Colarossi L.
        • Lunde B.
        • Jacobs A.R.
        • Porsch L.M.
        • Paul M.E.
        Safety of digoxin for fetal demise before second-trimester abortion by dilation and evacuation.
        Contraception. 2012; 85: 144-149https://doi.org/10.1016/j.contraception.2011.05.016
        • Steward R.
        • Melamed A.
        • Kim R.
        • Nucatola D.
        • Gatter M.
        Infection and extramural delivery with use of digoxin as a feticidal agent.
        Contraception. 2012; 85: 150-154https://doi.org/10.1016/j.contraception.2011.01.005
        • Borgatta L.
        • Betstadt S.J.
        • Reed A.
        • Feng K.
        Relationship of intraamniotic digoxin to fetal demise.
        Contraception. 2010; 81: 328-330https://doi.org/10.1016/j.contraception.2009.12.001
        • Gariepy A.M.
        • Chen B.A.
        • Hohmann H.L.
        • Achilles S.L.
        • Russo J.A.
        • Creinin M.D.
        Transvaginal administration of intraamniotic digoxin prior to dilation and evacuation.
        Contraception. 2013; 87: 76-80https://doi.org/10.1016/j.contraception.2012.07.019
        • Charmaz K.
        Grounded theory in global perspective: Reviews by international researchers.
        Qual Inq. 2014; 20: 1074-1084https://doi.org/10.1177/1077800414545235
        • Tocce K.
        • Sheeder J.L.
        • Edwards L.J.
        • Teal S.B.
        Feasibility, effectiveness and safety of transvaginal digoxin administration prior to dilation and evacuation.
        Contraception. 2013; 88: 706-711https://doi.org/10.1016/j.contraception.2013.08.005
        • Erlandsson K.
        • Lindgren H.
        • Malm M.-C.
        • Davidsson-Bremborg A.
        • Rådestad I.
        Mothers’ experiences of the time after the diagnosis of an intrauterine death until the induction of the delivery: a qualitative Internet-based study.
        J Obstet Gynaecol Res. 2011; 37: 1677-1684https://doi.org/10.1111/j.1447-0756.2011.01603.x
        • Lee S.J.
        • Ralston H.J.P.
        • Drey E.A.
        • Partridge J.C.
        • Rosen M.A.
        Fetal pain: a systematic multidisciplinary review of the evidence.
        JAMA. 2005; 294: 947-954https://doi.org/10.1001/jama.294.8.947
        • Rocca C.H.
        • Kimport K.
        • Gould H.
        • Foster D.G.
        Women’s emotions one week after receiving or being denied an abortion in the United States.
        Perspect Sex Reprod Health. 2013; 45: 122-131https://doi.org/10.1363/4512213
        • Bianchi-Demicheli F.
        Psychiatric and psychological consequences of abortion.
        Rev Med Suisse. 2007; 3 ([404, 406–7]): 401-402
        • Cougle J.R.
        • Reardon D.C.
        • Coleman P.K.
        Generalized anxiety following unintended pregnancies resolved through childbirth and abortion: a cohort study of the 1995 National Survey of Family Growth.
        J Anxiety Disord. 2005; 19: 137-142https://doi.org/10.1016/j.janxdis.2003.12.003
        • Harris L.H.
        Stigma and abortion complications in the United States.
        Obstet Gynecol. 2012; 120: 1472-1474https://doi.org/10.1097/AOG.0b013e3182723d82
        • Renner R.
        • Nichols M.D.
        • Jensen J.T.
        • Li H.
        • Edelman A.B.
        Paracervical block for pain control in first-trimester surgical abortion: a randomized controlled trial.
        Obstet Gynecol. 2012; 119: 1030-1037https://doi.org/10.1097/AOG.0b013e318250b13e
        • Kimport K.
        • Foster K.
        • Weitz T.A.
        Social sources of women’s emotional difficulty after abortion: Lessons from women’s abortion narratives.
        Perspect Sex Reprod Health. 2011; 43: 103-109https://doi.org/10.1363/4310311
        • Wan T.T.H.
        • Terry A.
        • Cobb E.
        • McKee B.
        • Tregerman R.
        • Barbaro S.D.S.
        Strategies to modify the risk of heart failure readmission: A systematic review and meta-analysis.
        Health Serv Res Manag Epidemiol. 2017; 4 ([2333392817701050])https://doi.org/10.1177/2333392817701050
        • Stacey D.
        • Légaré F.
        • Lewis K.
        • Barry M.J.
        • Bennett C.L.
        • Eden K.B.
        • et al.
        Decision aids for people facing health treatment or screening decisions.
        Cochrane Database Syst Rev. 2017; 4: CD001431https://doi.org/10.1002/14651858.CD001431.pub5
        • Ogden J.
        • Daniells E.
        • Barnett J.
        When is choice a good thing? An experimental study of the impact of choice on patient outcomes.
        Psychol Health Med. 2009; 14: 34-47https://doi.org/10.1080/13548500802069006
        • Clark N.M.
        • Janz N.K.
        • Dodge J.A.
        • Mosca L.
        • Lin X.
        • Long Q.
        • et al.
        The effect of patient choice of intervention on health outcomes.
        Contemp Clin Trials. 2008; 29: 679-686https://doi.org/10.1016/j.cct.2008.04.002
        • Teal S.B.
        • Dempsey-Fanning A.
        • Westhoff C.
        Predictors of acceptability of medication abortion.
        Contraception. 2007; 75: 224-229https://doi.org/10.1016/j.contraception.2006.10.008
        • Wallace R.
        • DiLaura A.
        • Dehlendorf C.
        “Every person’s just different”: Women’s experiences with counseling for early pregnancy loss management.
        Womens Health Issues. 2017; https://doi.org/10.1016/j.whi.2017.02.008